Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.62 |
| ▸ | AKT2 | P31751 | 2/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | TACR1 | P25103 | 5/20 | 0.40 |
| ▸ | AKT1 | P31749 | 1/20 | 0.37 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.37 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.36 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.36 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6198471 | 0.98 | OPRM1 (0.61) | OPRM1AKT2HTR2ATACR1AKT1 | |
| Hydrochloric Acid SCHEMBL2523744 | 0.80 | OPRM1 (0.56) | OPRM1AKT2HTR2ATACR1 | |
| SCHEMBL738518 | 0.79 | OPRM1 (1.00) | OPRM1AKT2HTR2ATACR1AKT1 | |
| SCHEMBL6198602 | 0.79 | OPRM1 (0.69) | OPRM1AKT2HTR2ATACR1LTA4H | |
| Hydrochloric Acid SCHEMBL1765284 | 0.77 | OPRM1 (0.95) | OPRM1AKT2HTR2ATACR1MEN1 | |
| SCHEMBL6969149 | 0.75 | OPRM1 (0.62) | OPRM1AKT2HTR2ATACR1AKT1 | |
| Hydrochloric Acid SCHEMBL6198470 | 0.74 | OPRM1 (0.61) | OPRM1AKT2HTR2ATACR1AKT1 | |
| SCHEMBL1977652 | 0.73 | OPRM1 (0.77) | OPRM1AKT2HTR2ATACR1AKT1 | |
| SCHEMBL1257446 | 0.73 | OPRM1 (0.77) | OPRM1AKT2HTR2ATACR1AKT1 | |
| SCHEMBL7885473 | 0.72 | OPRM1 (0.83) | OPRM1AKT2HTR2ATACR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6620815-B1 | Selective antagonists for human alpha 1A receptors; benign prostatic hyperplasia, impotency, cardiac arrhythmia treatment; anticholesterol agents; intraocular pressure reduction | SYNAPTIC PHARMACEUTICAL CORPORATION | 2003-09-16 | — | — | US | disclosed |
| EP-0988295-A4 | HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF | SYNAPTIC PHARMA CORP (US) | 2003-08-13 | — | — | EP | disclosed |
| US-6159990-A | Oxazolidinones as α1A receptor antagonists | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 2000-12-12 | — | — | US | disclosed |
| EP-0988295-A1 | HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 2000-03-29 | — | — | EP | disclosed |
| WO-1998057940-A1 | HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF | SYNAPTIC PHARMACEUTICAL CORPORATION (US) | 1998-12-23 | — | — | WO | disclosed |